1. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research;Anderson;Cancer Biother Radiopharm.,2009
2. ANSI/NCSL Z540-2-1997, 1997. U.S. Guide to the Expression of Uncertainty in Measurement, American National Standard for Expressing Uncertainty. (NCSL, Boulder, CO).
3. Asabella A.N., Cascini G.L., Altini C., Paparella D., Notaristefano A., Rubini G., 2014. The CopperRadioisotopes: A Systematic Review with Special Interest to 64Cu. BioMed Research International, Volume 2014, Article ID 786463, 9 pages. http://dx.doi.org/10.1155/2014/786463.
4. Bé M.-.M., Chisté V., Dulieu C., Mougeot X., Chechev V.P., Kuzmenko N.K., Kondev F.G., Luca A., Galán M., Nichols A.L., Arinc A., Pearce A., Huang X., Wang B., 2011. Monographie BIPM-5, Table of Radionuclides, Vol. 6 – A = 22 to 242. 〈http://www.nucleide.org/DDEP_WG/DDEPdata.htm〉.
5. Standardization, decay data measurements and evaluation of 64Cu;Bé;Appl. Radiat. Isot.,2012